FDA Inspection
Swiss Caps AGSwiss Caps AG – FDA Inspection, Jun 29, 2023
Record Details
This FDA Inspection record concerns Swiss Caps AG, with an inspection on June 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 34e19ab3-e768-4022-be67-772f92f7d77b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1258616
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Swiss Caps AG
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 27, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 16, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 31, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 23, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 25, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Swiss Caps AG
- FDA Inspection 1109706 - 2019-09-27
- FDA Inspection 1014881 - 2017-06-16
- FDA Inspection 905387 - 2014-10-31
- FDA Inspection 811530 - 2012-11-23
- FDA Inspection 707937 - 2010-11-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.